Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

409 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Mindfulness-based stress reduction in patients with interstitial lung diseases: a pilot, single-centre observational study on safety and efficacy.
Sgalla G, Cerri S, Ferrari R, Ricchieri MP, Poletti S, Ori M, Garuti M, Montanari G, Luppi F, Petropulacos K, Richeldi L. Sgalla G, et al. Among authors: richeldi l. BMJ Open Respir Res. 2015 Mar 10;2(1):e000065. doi: 10.1136/bmjresp-2014-000065. eCollection 2015. BMJ Open Respir Res. 2015. PMID: 25806113 Free PMC article.
Levels of circulating endothelial cells are low in idiopathic pulmonary fibrosis and are further reduced by anti-fibrotic treatments.
De Biasi S, Cerri S, Bianchini E, Gibellini L, Persiani E, Montanari G, Luppi F, Carbonelli CM, Zucchi L, Bocchino M, Zamparelli AS, Vancheri C, Sgalla G, Richeldi L, Cossarizza A. De Biasi S, et al. Among authors: richeldi l. BMC Med. 2015 Nov 9;13:277. doi: 10.1186/s12916-015-0515-0. BMC Med. 2015. PMID: 26552487 Free PMC article.
Novel drug targets for idiopathic pulmonary fibrosis.
Sgalla G, Cocconcelli E, Tonelli R, Richeldi L. Sgalla G, et al. Among authors: richeldi l. Expert Rev Respir Med. 2016 Apr;10(4):393-405. doi: 10.1586/17476348.2016.1152186. Epub 2016 Feb 26. Expert Rev Respir Med. 2016. PMID: 26854382
The safety of new drug treatments for idiopathic pulmonary fibrosis.
Fletcher S, Jones MG, Spinks K, Sgalla G, Marshall BG, Limbrey R, Richeldi L. Fletcher S, et al. Among authors: richeldi l. Expert Opin Drug Saf. 2016 Nov;15(11):1483-1489. doi: 10.1080/14740338.2016.1218470. Epub 2016 Aug 17. Expert Opin Drug Saf. 2016. PMID: 27532218 Review.
Idiopathic pulmonary fibrosis.
Richeldi L, Collard HR, Jones MG. Richeldi L, et al. Lancet. 2017 May 13;389(10082):1941-1952. doi: 10.1016/S0140-6736(17)30866-8. Epub 2017 Mar 30. Lancet. 2017. PMID: 28365056 Review.
409 results